Skip Navigation
Menu
ACP Journal Club |19 December 2017

Guided early deescalation of antiplatelet treatment was noninferior to usual prasugrel care in PCI-treated ACS

Eric R. Bates, MD

Article, Author, and Disclosure Information
FULL TEXT
Sibbing D, Aradi D, Jacobshagen C, et al; TROPICAL-ACS Investigators. Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial. Lancet. 2017;390:1747-57. 28855078

Cardiology:

In patients who had percutaneous coronary intervention (PCI) for an acute coronary syndrome (ACS), what are the relative efficacy and safety of guided early deescalation of antiplatelet treatment and usual care with prasugrel for ischemic and bleeding events?
Randomized controlled trial (RCT) (Testing Responsiveness To Platelet Inhibition On Chronic Antiplatelet Treatment For Acute Coronary Syndromes [TROPICAL-ACS] trial). ClinicalTrials.gov NCT01959451; EudraCT 2013-001636-22.
Concealed.*
Blinded* (outcome assessors).
FULL TEXT
PDF
Not Available
Citations
Citation

Bates ER. Guided early deescalation of antiplatelet treatment was noninferior to usual prasugrel care in PCI-treated ACS. Ann Intern Med. ;167:JC69. doi: 10.7326/ACPJC-2017-167-12-069

Download citation file:

© 2019

×
Permissions

Published: Ann Intern Med. 2017;167(12):JC69.

DOI: 10.7326/ACPJC-2017-167-12-069

©
2017 American College of Physicians
0 Citations

Related Articles
In PCI-treated ACS, switching from aspirin + a newer P2Y12 blocker to aspirin + clopidogrel reduced adverse events
Annals of Internal Medicine; 167 (6): JC28
Cost-Effectiveness of Genotype-Guided and Dual Antiplatelet Therapies in Acute Coronary Syndrome
Annals of Internal Medicine; 160 (4): 221-232
Management of Patients Undergoing Percutaneous Coronary Revascularization
Annals of Internal Medicine; 139 (2): 123-136
Tumor Necrosis Factor Inhibitors and Cancer Recurrence in Swedish Patients With Rheumatoid Arthritis: A Nationwide Population-Based Cohort Study
Annals of Internal Medicine; 169 (5): 291-299
View MoreView Less

Journal Club
In PCI-treated ACS, switching from aspirin + a newer P2Y12 blocker to aspirin + clopidogrel reduced adverse events
Annals of Internal Medicine; 167 (6): JC28
In left main CAD, CABG reduced major adverse cardiac or cerebrovascular events at 5 years compared with PCI
Annals of Internal Medicine; 166 (4): JC20
After treating unprovoked PE with VKAs for 6 months, warfarin for 18 more months reduced a composite of VTE or major bleeding
Annals of Internal Medicine; 163 (10): JC6
Self-monitoring of blood glucose did not improve HbA1c or QoL at 1 year in non–insulin-treated type 2 diabetes
Annals of Internal Medicine; 167 (8): JC46
View MoreView Less

Related Point of Care
Palliative Care
Annals of Internal Medicine; 168 (5): ITC33-ITC48
Clostridioides difficile Infection
Annals of Internal Medicine; 169 (7): ITC49-ITC64
Systemic Lupus Erythematosus
Annals of Internal Medicine; 159 (7): ITC4-1
Polymyalgia Rheumatica
Annals of Internal Medicine; 166 (9): ITC65-ITC80
View MoreView Less

Related Topics
Cardiology
Coronary Heart Disease
Percutaneous Coronary Intervention

Cardiology, Coronary Heart Disease, Percutaneous Coronary Intervention.

PubMed Articles
High and low on-treatment platelet reactivity to P2Y12 inhibitors in a contemporary cohort of acute coronary syndrome patients undergoing percutaneous coronary intervention.
Thromb Res 2019;
C-reactive protein and prognosis after percutaneous coronary intervention and bypass graft surgery for left main coronary artery disease: Analysis from the EXCEL trial.
Am Heart J 2019;
View More

Results provided by: PubMed

CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2019 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×